[Aiming serotherapy of HUS-IVIG, serum lipoprotein and C3].
Nishioka
K
K
Japanese Red Cross.
Imai
M
M
D000818:Animals; D003176:Complement C3 / Q000502:physiology; D004927:Escherichia coli Infections; D019453:Escherichia coli O157; D006471:Gastrointestinal Hemorrhage / Q000209:etiology; D006463:Hemolytic-Uremic Syndrome / Q000209:etiology / Q000628:therapy*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage; D008074:Lipoproteins / Q000502:physiology
D003176:Complement C3; D016756:Immunoglobulins, Intravenous; D008074:Lipoproteins